Hypertonic Saline in Posterior Spinal Fusion
Launched by JOSEPH D. TOBIAS · Feb 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of two different types of saline solutions used during brain surgery in young patients aged 8 to 21. One group of participants will receive a standard 0.9% normal saline solution, while the other group will receive a special buffered 2% hypertonic saline solution. The main goal is to see how these fluids affect the body's chemistry during surgery, specifically looking at changes in acid-base balance and electrolyte levels. Researchers also want to find out which fluid requires less volume for effective treatment during the operation.
To be eligible for this study, participants must be scheduled for a specific type of brain surgery that involves monitoring blood pressure through an arterial line and need to have two intravenous lines placed. If the surgery does not require these specific monitoring techniques, the patient will not be eligible. As the trial is not yet recruiting, interested families will need to wait for further announcements regarding participation. This study aims to improve care for young patients undergoing crucial neurological procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \> or = 10 years of age
- • ASA 1-3
- • Undergoing a PSF procedure requiring two peripheral intravenous infusions and an arterial cannula
- Exclusion Criteria:
- • Arterial cannula is not indicated for the surgical procedure
- • Two peripheral intravenous cannulas are not required
- • An invasive arterial cannula cannot be placed
About Joseph D. Tobias
Joseph D. Tobias is a distinguished clinical trial sponsor with extensive expertise in conducting and overseeing clinical research initiatives. Committed to advancing medical knowledge and improving patient outcomes, he leverages a robust network of healthcare professionals and researchers to design, implement, and manage innovative clinical studies. With a focus on ethical standards and regulatory compliance, Joseph D. Tobias ensures that all trials adhere to the highest quality benchmarks, fostering collaboration and transparency throughout the research process. His dedication to scientific rigor and patient safety positions him as a trusted leader in the clinical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported